-W A Robinson Researcher Activity Profile

Research Author Detailed Information 

W A Robinson Publication Rate By Year

W A Robinson has published 1 paper(s) in 1976, 1 paper(s) in 1985, 1 paper(s) in 1995, 3 paper(s) in 2007, 2 paper(s) in 2008, for a total of 8 research publications in total.

W A Wa Robinson Author Information

LAST NAME: robinson

FIRST NAME: W A

INITIALS: wa

AFFILIATION:

Papers

W A Robinson's Publication Record

1. Vitamin E improves cell-mediated immunity in the burned mouse: a preliminary study. Year Published: 1985
2. Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-alpha 2b on human melanoma cells in culture by a mixture of vitamins. Year Published: 1995
Department of Radiology, University of Colorado Health Sciences Center, Denver 80262.
3. EGFR-mutant lung adenocarcinoma in a patient with Li-Fraumeni syndrome. Year Published: 2007
Department of Medicine, University of Colorado at Denver and Health Sciences Center, Aurora, CO, USA.
4. Genetic mutations involved in melanoma: a summary of our current understanding. Year Published: 2007
Department of Dermatology and Pathology, University of Colorado Health Sciences Center, P.O. Box 6510, Mail Stop F703, Aurora, CO 80045, USA. whitney.high@uchsc.edu
5. A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma. Year Published: 2008
Cutaneous Oncology Program, University of Colorado Health Sciences Center, PO Box 6510, Mail Stop F703, Aurora, CO, 80045, USA, karl.lewis@uchsc.edu.
6. Platelet-derived growth factor receptor alpha mutational status and immunohistochemical expression in Merkel cell carcinoma: implications for treatment with imatinib mesylate. Year Published: 2008
Department of Dermatology/Dermatopathology, Methodist Physicians Clinic, Omaha, NE, USA.
7. Genetic mutations involved in melanoma: a summary of our current understanding. Year Published: 2007
Department of Dermatology and Pathology, University of Colorado Health Sciences Center, P.O. Box 6510, Mail Stop F703, Aurora, CO 80045, USA. whitney.high@uchsc.edu
8. Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease. Year Published: 1976